RNAZ short interest
TransCode Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 52,062 |
|---|---|
| Change vs prior report | -9,341 (-15.2%) |
| Change over six months | +4.2% |
| Days to cover | 1.00 (sector: 3.78) |
| Average daily volume | 68,425 |
| Rank in Healthcare | #779 of 922 by days to cover |
RNAZ short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 52,062 | -15.2% | 1.00 | 68,425 |
| 2026-09-15 | 61,403 | +33.5% | 1.82 | 33,820 |
| 2026-08-31 | 45,978 | +48.8% | 1.00 | 122,489 |
| 2026-08-14 | 30,910 | +9.4% | 1.51 | 20,407 |
| 2026-07-31 | 28,252 | -18.0% | 1.83 | 15,474 |
| 2026-07-15 | 34,446 | -34.8% | 1.00 | 41,287 |
| 2026-06-30 | 52,823 | -6.5% | 2.59 | 20,394 |
| 2026-06-15 | 56,527 | +100.9% | 1.00 | 230,735 |
| 2026-05-29 | 28,142 | -22.4% | 1.87 | 15,089 |
| 2026-05-15 | 36,265 | +1.4% | 4.07 | 8,913 |
| 2026-04-30 | 35,757 | -12.9% | 7.56 | 4,731 |
| 2026-04-15 | 41,071 | -17.8% | 6.39 | 6,431 |
| 2026-03-31 | 49,976 | -26.9% | 6.09 | 8,206 |
| 2026-03-13 | 68,334 | -11.9% | 5.39 | 12,689 |
| 2026-02-27 | 77,552 | -31.9% | 4.48 | 17,316 |
| 2026-02-13 | 113,877 | +228.7% | 1.00 | 1,132,489 |
| 2026-01-30 | 34,640 | -42.0% | 1.61 | 21,509 |
| 2026-01-15 | 59,701 | +0.4% | 1.00 | 225,297 |
| 2025-12-31 | 59,476 | +43.2% | 1.68 | 35,362 |
| 2025-12-15 | 41,544 | +9.4% | 2.55 | 16,288 |
| 2025-11-28 | 37,989 | +6.4% | 4.92 | 7,717 |
| 2025-11-14 | 35,717 | +32.0% | 2.31 | 15,450 |
| 2025-10-31 | 27,054 | -53.9% | 1.06 | 25,598 |
| 2025-10-15 | 58,698 | +34.9% | 1.00 | 742,136 |
| 2025-09-30 | 43,523 | -25.9% | 3.27 | 13,302 |
import finzdata as yf
yf.Ticker("RNAZ").short_interest # every report since 2017
yf.Client().short_interest(["RNAZ"], start="2018-01-01")Healthcare short interest · RNAZ price history · Who owns RNAZ · All short interest